Trial of AVN-944 in Patients With Advanced Hematologic Malignancies

NCT00273936 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Leukemia
Chronic Leukemia
Multiple Myeloma
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Waldenstrom's Macroglobulinemia

Interventions

DRUG: AVN-944 capsules for oral administration

Sponsor

Vertex Pharmaceuticals Incorporated